Article Abstract
Letter to the Editor
Sir:
Nefazodone is a relatively new antidepressant drug.Preclinical data suggest that it has potent antagonistic effects onpostsynaptic serotonin-2 (5-HT2) receptors and moderate presynapticserotonin and norepinephrine reuptake inhibiting propertieswhile demonstrating low affinity for other receptor types(including other 5-HT receptors and cholinergic, a-adrenergic,dopaminergic, and histaminergic receptors). It has to date beenshown to be safe and well tolerated, with clinical efficacycomparable to that of selective serotonin reuptake inhibitors(SSRIs).
From the Editors
Are you a healthcare provider?
Add your NPI to personalize your JCP experience.
Download Free PDF
This PDF is free for all visitors!
